A decline in expression of CXCL12, the natural antagonist of CXCR4, occurs in AD and is linked to neurocognitive events both on the behavioral and molecular level revealing a Rac1-dependent effect on actin polymerization [46, 47]. This evidence concerns the gene CXCR4 and Alzheimer disease.